Early life high fructose exposure is associated with increased prevalence of adolescent anxiety disorders

Researchers investigated whether exposure to high fructose in early life directly affects essential microglia function.

Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis – Biotech Investments

Issuer: Immunic AG / Key word(s): Conference 18.09.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents Key

September 19, 2024

Study reveals overlooked cognitive deficits in adults with documented childhood maltreatment

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and City University of New York suggests that the cognitive

August 14, 2024

Durable Weight Loss Follows Just a Few Injections of Novel Drug

A once-monthly injectable weight management agent safely induced durable weight loss in a phase I human trial. At the highest dose tested, patients with overweight

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.